Johnson & Johnson Rebounds Below ‘Reversion to the Mean’
Health care giant Johnson & Johnson (JNJ) is a component of the Dow Jones Industrial Average. The company has a winning streak of beating earnings per share (EPS) estimates in 30 consecutive quarters. The stock is in bear market territory at 20.3% below its all-time intraday high of $154.50 set on Feb. 6, but the…